![Rick Ryan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rick Ryan
Directeur/Membre du Conseil chez
Aptimmune Biologics, Inc.
Profil
Rick has over 35 years of experience in business management and new business/technology development in the life science industry.
He has held executive leadership positions in multinational corporations as well as early-stage ventures.
He retired from Millipore in 2010, where he was VP of the Drug Discovery & Development business unit mid 2006 through 2010.
Millipore was acquired by Merck KGaA in mid-2010, and Rick supported several aspects of the integration process with EMD and Serono.
Prior to Millipore, Rick was the President of LINCO Research, a company that developed and commercialized diagnostic kits and services for biomedical research.
LINCO was a leader in the development of multiplex assays for the Luminex platform.
Rick started his career in biotechnology at Monsanto, where he held several Director level roles in technology and business management, including Commercial Development, Strategic Planning and International Markets.
Currently, Rick serves as CEO of Apertus Pharmaceuticals, a developer and manufacturer of generic API and finished dose formulations.
Rick received a B.S.
in Chemistry (Central College, Pella IA), his PhD in Biochemistry (University of Illinois), a Post Doctoral Fellowship (American Cancer Society – U of Wisconsin) and his executive MBA (Washington University in St. Louis).
He is a Distinguished Alumni award recipient from the Olin School of Business at Wash U.
Postes actifs de Rick Ryan
| Sociétés | Poste | Début |
|---|---|---|
Cultivation Capital LLC
 Cultivation Capital LLC Investment ManagersFinance Cultivation Capital invests in companies located in the United States. The firm focuses on life sciences and health tech, software & IT, agriculture tech, fintech and geospatial tech sectors. It participates in seed and early-stage transactions with an investment size of USD 100,000-3.5 million. It acts as a lead investor and takes a seat on the board of directors. It makes follow-on investments. | Private Equity Investor | 01/05/2013 |
Aptimmune Biologics, Inc.
 Aptimmune Biologics, Inc. BiotechnologyHealth Technology Develops and markets mucosal vaccines | Directeur/Membre du Conseil | - |
Gateway Region Young Men's Christian Association
 Gateway Region Young Men's Christian Association Services to the Health IndustryHealth Services Provides social services for the youth | Consultant / Advisor | 01/08/2004 |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/02/2017 |
Anciens postes connus de Rick Ryan
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK KGAA | President | 01/01/2006 |
| ZOETIS INC. | Corporate Officer/Principal | 31/12/1998 |
| BAYER AG | Corporate Officer/Principal | 31/12/1996 |
The Winfield Group LLC | President | - |
Formation de Rick Ryan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
University of Missouri
University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zoetis, Inc.
 Zoetis, Inc. Pharmaceuticals: MajorHealth Technology Develops animal vaccines and prescriptions medicines | Health Technology |
Central College
 Central College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cultivation Capital LLC
Cultivation Capital LLC Investment ManagersFinance Cultivation Capital invests in companies located in the United States. The firm focuses on life sciences and health tech, software & IT, agriculture tech, fintech and geospatial tech sectors. It participates in seed and early-stage transactions with an investment size of USD 100,000-3.5 million. It acts as a lead investor and takes a seat on the board of directors. It makes follow-on investments. | Finance |
Aptimmune Biologics, Inc.
Aptimmune Biologics, Inc. BiotechnologyHealth Technology Develops and markets mucosal vaccines | Health Technology |
Gateway Region Young Men's Christian Association
Gateway Region Young Men's Christian Association Services to the Health IndustryHealth Services Provides social services for the youth | Health Services |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Winfield Group LLC |
